Strikingly, all JAK1 LOF mutant tumor organoids had significant resistance to anti-tumor T cell-mediated killing relative to WT controls, with some mutants achieving survival comparable with antibody blockade of MHC-I or growing tumor organoids in the absence of T cells (Figure 7F). Here, JAK1 is linked to neoplasm.